Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: a systematic review and dose-response meta-analysis

HIGHLIGHTS

  • who: Yujie Zhao et al. from the Kyushu University, Japan have published the research: Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis, in the Journal: (JOURNAL) of 10/09/2022
  • what: This systematic review and doseresponse meta-analysis explored of the association between FGF23 levels and cardiovascular diseases and mortality risk in the general population. Although the analysis showed moderate heterogeneity, a robust association was observed between FGF23 levels and all-cause mortality.

SUMMARY

    The . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?